Loading...
 

Volume 34, Issue 4, December 2023



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(1):117-20
Investigating the Role of T-bet+ B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
Authors Information

14th Department of Internal Medicine, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

2Paediatric Immunology and Rheumatology Referral Centre, 1st Paediatric Department, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

3Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thermi, Thessaloniki, Greece

4Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece

54th Department of Internal Medicine, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece


A Sachinidis, M Trachana, A Taparkou, G Gavriilidis, P Verginis, F Psomopoulos, C Adamichou, D Boumpas, A Garyfallos

References
  1. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell [Internet] 2000;100(6):655–69. Available from: http://dx.doi.org/10.1016/s0092-8674(00)80702-3
  2. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004;20:477–94.
  3. Lugo-Villarino G, Ito S, Klinman DM, Glimcher LH. The adjuvant activity of CpGDNA requires T-bet expression in dendritic cells. Proc Natl Acad Sci USA 2005;102:13248–53.
  4. Peng SL, Li J, Lin L, Gerth A. The role of T-bet in B cells. Nat Immunol [Internet] 2003;4(11):1041; author reply 1041. Available from: http://dx.doi.org/10.1038/ni1103-1041a
  5. Gerth AJ, Lin L, Peng SL. T-bet regulates T-independent IgG2a class switching. Int Immunol [Internet] 2003;15(8):937–44. Available from: http://dx.doi.org/10.1093/intimm/dxg093
  6. Wang NS, Mcheyzer-Williams LJ, Okitsu SL, Burris TP, Reiner SL, Mcheyzer-Williams MG. Divergent transcriptional programming of class-specific B cell memory by T-bet and RORalpha. Nat Immunol 2012;13:604–11.
  7. Hao Y, O’Neill P, Naradikian MS, Scholz JL, Cancro MP. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood [Internet] 2011;118(5):1294–304. Available from: http://dx.doi.org/10.1182/blood-2011-01-330530
  8. Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c B-cell population is important for the development of autoimmunity. Blood 2011;118:1305–15.
  9. Rubtsova K, Rubtsov AV, Van Dyk LF, Kappler JW, Marrack P. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc Natl Acad Sci USA 2013;110:E3216-3224.
  10. Rubtsova K, Rubtsov AV, Halemano K, Li SX, Kappler JW, Santiago ML, et al. T cell production of IFNgamma in response to TLR7/IL-12 stimulates optimal B cell responses to viruses. PLoS One 2016;11.
  11. Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, et al. Cutting Edge: IL-4, IL-21, and IFN-gamma Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. J Immunol 2016;197:1023–8.
  12. Rubtsov PAV, Marrack K. T-bet expressing B cells-Novel target for autoimmune therapies? Cell Immunol 2017;321:35–9.
  13. Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P. CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs. J Immunol [Internet] 2015;195(1):71–9. Available from: http://dx.doi.org/10.4049/jimmunol.1500055
  14. Domeier PP, Chodisetti SB, Soni C, Schell SL, Elias MJ, Wong EB, et al. IFN-gamma receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity. J Exp Med 2016;213:715–32.
  15. Du SW, Arkatkar T, Jacobs HM, Rawlings DJ, Jackson SW. Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression. Eur J Immunol [Internet] 2019;49(1):170–8. Available from: http://dx.doi.org/10.1002/eji.201847641
  16. Colonna-Romano G, Bulati M, Aquino A, Pellicano M, Vitello S, Lio D, et al. A double-negative (IgD-CD27-) B cell population is increased in the peripheralblood of elderly people. Mech Ageing Dev. 2009;130:681–90.
  17. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol [Internet] 2007;178(10):6624–33. Available from: http://dx.doi.org/10.4049/jimmunol.178.10.6624
  18. Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to PathogenicResponses in Systemic Lupus Erythematosus. Immunity 2018;49:1–15.
  19. Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. Elife [Internet] 2019;8. Available from: http://dx.doi.org/10.7554/elife.41641
  20. González LA, Toloza SMA, McGwin G Jr, Alarcón GS. Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus [Internet] 2013;22(12):1214–24. Available from: http://dx.doi.org/10.1177/0961203313502571
  21. Boedigheimer MJ, Martin DA, Amoura Z, Sánchez-Guerrero J, Romero-Diaz J, Kivitz A, et al. Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis. Lupus Sci Med 2017 Sep 14;4(1):e000226.  
  22. Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf [Internet] 2017;16(3):411–9. Available from: http://dx.doi.org/10.1080/14740338.2017.1269168
  23. Burness CB, McCormack PL. Belimumab: in systemic lupus erythematosus. Drugs [Internet] 2011;71(18):2435–44. Available from: http://dx.doi.org/10.2165/11208440-000000000-00000
  24. Blair HA, Duggan ST. Belimumab: A review in systemic lupus erythematosus. Drugs [Internet] 2018;78(3):355–66. Available from: http://dx.doi.org/10.1007/s40265-018-0872-z
  25. Nehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol [Internet] 2020;21(9):1094–106. Available from: http://dx.doi.org/10.1038/s41590-020-0743-0